Newsfiscal.ai
Raymond James Initiates Coverage on Benitec Biopharma with Outperform Rating
· Published
Article summary
Raymond James has initiated coverage on Benitec Biopharma Inc. with an "Outperform" rating and a price target of $14.00 per share.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…